Patient Safety

Missouri Creates a Unique PDMP

By Connie Sinclair, Director, Regulatory Resource Center Until recently, Missouri was the only state without a Prescription Drug Monitoring Program (PDMP).  Growing evidence suggests that use of these state-run databases …

Improving Care Quality using ePrescribing: CancelRx

Electronic prescribing (ePrescribing) is ubiquitous, but there is still room for improvement. Many, including RAND researchers, put the CancelRx transaction at the top of the list, because of its implications for …

NCPDP Action Group Focused on Biologics and Biosimilars

By Brian Bamberger, Practice Lead, Life Sciences Biologics and biosimilars are starting to burst into the American market. Biosimilars are expected to quickly become mainstream in the near future because …

Biosimilars 101: Considerations for Health IT and Other Stakeholders

By Tony Schueth Biosimilars now are being introduced in the United States and are expected to rapidly become lower-cost, mainstream treatments for a range of chronic diseases, including cancer, rheumatoid …